SCHEMBL8124185

SCHEMBL8124185

Cc1ccc(O)c(C(=O)c2ccc(C(=O)O)cc2)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 8/20 0.48
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.45
PTGES O14684 1/20 0.45
ALOX5 P09917 1/20 0.45
DUSP3 P51452 1/20 0.45
KMT2A Q03164 1/20 0.45
MCL1 Q07820 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9381963 0.83 CA12 (0.46) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL8121538 0.82 KDM4E (0.51) SRD5A2KDM4ELMNAHSD17B10TP53
SCHEMBL8129479 0.81 ALDH1A1 (0.47) SRD5A2KDM4ELMNAHSD17B10ALDH1A1
SCHEMBL8132123 0.79 SRD5A2 (0.42) SRD5A2KDM4ELMNAHSD17B10MEN1
SCHEMBL8121537 0.79 GABRA1 (0.44) SRD5A2KDM4ELMNAHSD17B10PTGS2
SCHEMBL8128858 0.79 HTT (0.54) SRD5A2LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL24445654 0.76 THRB (0.50) KDM4EMEN1KMT2AMCL1ALDH1A1
SCHEMBL18329485 0.73 MEN1 (0.45) KDM4EMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL9752047 0.73 SRD5A2 (0.59) SRD5A2KDM4ESMN1; SMN2ALDH1A1CA12
SCHEMBL1495242 0.72 CYP3A4 (0.44) MEN1KMT2AMCL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663393-B1 3-Amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors HOFFMANN LA ROCHE (CH) 2000-07-05 EP claimed
US-5583222-A ANTIINFLAMMATORY AGENTS FOR TREATMENT OF SKIN DISORDERS HOFFMANN-LA ROCHE INC. (US) 1996-12-10 US claimed
EP-0663393-A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP claimed
EP-0663393-B1 3-Amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors HOFFMANN LA ROCHE (CH) 2000-07-05 EP disclosed
US-5914406-A ENZYME INHIBITOR; USEFUL FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS AND ALOPECIA HOFFMAN-LA ROCHE INC. (US) 1999-06-22 US disclosed
US-5750706-A TREATMENT OF INFLAMMATORY SKIN DISORDERS AND ALOPECIA HOFFMANN-LA ROCHE INC. (US) 1998-05-12 US disclosed
US-5583222-A ANTIINFLAMMATORY AGENTS FOR TREATMENT OF SKIN DISORDERS HOFFMANN-LA ROCHE INC. (US) 1996-12-10 US disclosed
EP-0663393-A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP disclosed